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PDZRN3 is a member of the PDZ domain–containing RING ﬁnger family of proteins. We previously showed that
PDZRN3 is essential for the differentiation of C2C12 mouse mesenchymal progenitor cells into myotubes. Mesenchymal
progenitor cells differentiate into osteoblasts, chondrocytes, and adipocytes in addition to myotubes, and we have now
examined the potential role of PDZRN3 in the differentiation of C2C12 cells into osteoblasts. The abundance of PDZRN3
in C2C12 cells was increased after the induction of osteoblast differentiation by exposure to bone morphogenetic protein
(BMP)-2 in low-serum medium. Depletion of PDZRN3 in C2C12 cells by RNA interference resulted in marked enhance-
ment of the BMP-2–induced up-regulation of alkaline phosphatase (ALP) activity. Dkk1, an inhibitor of Wnt signaling,
markedly attenuated the enhancement of the BMP-2–induced increase in ALP activity by PDZRN3 depletion. The
up-regulation of ALP activity by Wnta3a was also promoted by depletion of PDZRN3. Furthermore, the expression and
Wnt3a-induced phosphorylation of LRP6 as well as the increase in the cytosolic abundance of -catenin induced by Wnt3a
were potentiated in PDZRN3-depleted cells. These results indicate that PDZRN3 plays an important role in negative
feedback control of BMP-2–induced osteoblast differentiation in C2C12 cells through inhibition of Wnt–-catenin
signaling.
INTRODUCTION
PDZ (PSD-95/Discs-large/ZO-1) domains function as pro-
tein-protein recognition modules and mediate clustering of
signaling molecules and organization of protein networks.
More than 250 PDZ domains in more than 150 proteins are
encoded in the human genome. Among PDZ domain–con-
taining proteins, members of the PDZRN (PDZ domain–
containing RING ﬁnger) family contain an NH2-terminal
RING ﬁnger, two or four PDZ domains, and a COOH-
terminal consensus PDZ domain–binding motif (Katoh,
2004). PDZRN3 and PDZRN4 contain two PDZ domains,
but the functions of this subfamily of PDZRN proteins are
largely unknown.
We previously cloned PDZRN3 cDNA from a human
heart library with the use of a yeast two-hybrid screen for
proteins that bind to the PDZ domains of PSD-95 (Ko et al.,
2006). The PDZRN3 protein was found to be expressed in a
variety of human tissues including heart, skeletal muscle,
liver, and brain. We showed that PDZRN3 is essential for
myogenic differentiation from myoblasts to myotubes with
the use of C2C12 mouse mesenchymal progenitor cells and
that its expression is up-regulated in vivo during regenera-
tion of mouse skeletal muscle from satellite cells (Ko et al.,
2006). In addition, PDZRN3 was shown by others to regulate
surface expression of muscle-speciﬁc receptor tyrosine ki-
nase (MuSK) by functioning as a synapse-associated E3
ubiquitin ligase (Lu et al., 2007). PDZRN3 thus plays impor-
tant roles in muscle differentiation and development.
Mesenchymal progenitor cells differentiate into osteo-
blasts, chondrocytes, and adipocytes in addition to myo-
tubes (Prockop, 1997). Bone morphogenetic proteins (BMPs)
are members of the transforming growth factor  superfam-
ily of proteins. BMP-2 inhibits myotube formation by C2C12
cells and shifts the differentiation pathway to the osteoblas-
tic lineage (Katagiri et al., 1994). Ablation of BMP signaling
has been shown to result in various skeletal and extraskel-
etal developmental abnormalities in vivo (Zhao, 2003).
BMP-2 interacts with BMP receptor 1A (BMPR1A) or
BMPR1B, both of which are serine-threonine kinases, as well
as with their coreceptor BMPR2. Signaling events down-
stream of BMP receptor activation include phosphorylation
of Smad1, Smad5, and Smad8, interaction of these phos-
phorylated Smad proteins with the comediator Smad4, nu-
clear translocation of the Smad complexes, and activation of
gene transcription (Canalis et al., 2003; Miyazono et al., 2010).
In addition to this Smad pathway, non-Smad pathways
involving activation of the mitogen-activated protein ki-
nases (MAPKs) c-Jun NH2-terminal kinase (JNK), p38, and
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3269extracellular signal–regulated kinase (ERK) also play impor-
tant roles in BMP signaling (Moustakas and Heldin, 2005;
Zhang, 2009). Furthermore, BMP-2 induces expression of
Wnt ligands, and Wnt–-catenin signaling is required for
osteoblast differentiation (Chen et al., 2007). We have now
investigated the possible role of PDZRN3 in BMP-2–induced
differentiation of C2C12 cells into osteoblasts.
MATERIALS AND METHODS
Materials
Recombinant human BMP-2, mouse Wnt3a, and human Dkk1 were obtained
from R&D Systems (Minneapolis, MN). Murine Wnt3a–containing condi-
tioned medium was prepared from L Wnt-3A cells (CRL-2647; American
Type Culture Collection, Manassas, VA). Protease inhibitor cocktail and phos-
phatase inhibitor cocktail were obtained from Roche (Branchburg, NJ), and
p-nitrophenyl phosphate (pNPP), naphthol AS-MX phosphate, and fast blue
BB salt were from Sigma-Aldrich (St. Louis, MO). Polyclonal antibodies to
PDZRN3 were generated in rabbits with the use of a histidine-tagged NH2-
terminal fragment of human PDZRN3 (amino acids 4-84) as antigen; the
antibodies were puriﬁed from serum by afﬁnity chromatography with a
glutathione S-transferase fusion protein of the antigen. Rabbit polyclonal
antibodies to ERK1/2 (KAP-MA001) or to -catenin (RB-1491) were obtained
from Assay Designs (Ann Arbor, MI) and Thermo Scientiﬁc (Fremont, CA),
respectively. Rabbit polyclonal antibodies to phosphorylated Smad1 linker
(Ser206, 9553), to dishevelled2 (3216), to phosphorylated -catenin (Ser33/37,
Thr41; 9561), or to phosphorylated low-density lipoprotein receptor-related
protein 6 (LRP6) (Ser1490, 2568) as well as rabbit monoclonal antibodies to
phosphorylated Smad1/5 (Ser463/465; 9516) or to Axin1 (2087) were from Cell
Signaling Technology (Danvers, MA). Rabbit polyclonal antibodies to
Smad1/5/8 (sc-6031-R), to JNK (sc-571), or to adenomatous polyposis coli
(APC; sc-896); goat polyclonal antibodies to frizzled1 (sc-30428), to frizzled4
(sc-66450), to frizzled6 (sc-32148), or to LRP5 (sc-21389); as well as mouse
monoclonal antibodies to GSK3/ (sc-7291) or to LRP6 (sc-25317) were from
Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit monoclonal antibodies to
phosphorylated JNK1 (Tyr185)/JNK2 (Tyr185)/JNK3 (Tyr223) (EP1597Y) were
from Epitomics (Burlingame, CA). Mouse monoclonal antibodies to phos-
phorylated ERK1/2 (Thr202, Tyr204; 612358), to p38 MAPK (612168), or to
phosphorylated p38 MAPK (Thr180, Tyr182; 612280) were from BD Biosciences
(San Jose, CA). Mouse monoclonal antibodies to -tubulin (T9026) were from
Sigma-Aldrich.
Cell Culture
C2C12 cells were obtained from American Type Culture Collection and were
maintained under 5% CO2 at 37°C in growth medium, consisting of DMEM
supplemented with 10% fetal bovine serum. Differentiation of the cells into
osteoblasts was induced at 90–95% conﬂuence by replacement of growth
medium with low-serum medium, consisting of DMEM supplemented with
2% horse serum (Invitrogen, Carlsbad, CA), and exposure of the cells to
various concentrations of BMP-2. Differentiation of C2C12 cells into myotubes
was induced by exposure to the low-serum medium without BMP-2.
RNA Interference
Recombinant adenoviral vectors encoding short hairpin RNAs (shRNAs) speciﬁc
for mouse PDZRN3 mRNA were constructed with the use of the pENTR/U6
shRNA plasmid and the Gateway-based pAd-BLOCK-iT DEST vector (Invitro-
gen). Two targeting sequences for PDZRN3 (KD-1 and KD-2) and a scrambled
version of KD-1 as a control (Scramb) were as follows: 5-GCTCAGAACAG-
GAGAATAACG-3(KD-1), 5-GGACACCTCGAACCAAGATGT-3(KD-2), and
5-GCAAGGACAGACACGGAATAT-3 (Scramb). For adenovirus-mediated ex-
pression of shRNA, C2C12 cells were seeded at a density of 2.5  104 cells per
well in a 24-well plate and cultured in growth medium for 12 h. The cells were
then infected with adenoviruses at a multiplicity of infection of 10 for 48 h, after
which differentiation was induced by replacement of the medium with low-
serum medium with or without BMP-2. An adenoviral vector encoding a form of
mouse PDZRN3 mRNA that is resistant to KD-1 was prepared by silent mutation
of the target sequence to 5-GCAGTGAGCAAGAAAACAATG-3.
Measurement of ALP Activity and ALP Staining
C2C12 cells were washed with phosphate-buffered saline and then lysed in a
solution containing 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 0.3% Triton
X-100, and protease inhibitor cocktail. Alkaline phosphatase (ALP) activity in
cell lysates was determined with pNPP (50 mg/ml) as substrate in an assay
buffer containing 50 mM Na2CO3 and 5 mM MgCl2. For histochemical anal-
ysis of ALP activity, cells were ﬁxed with 4% formaldehyde for 10 min at
room temperature, washed with phosphate-buffered saline, and incubated for
20 min at 37°C with a mixture of naphthol AS-MX phosphate (0.1 mg/ml),
0.5% N,N-dimethylformamide, 2 mM MgCl2, fast blue BB salt (0.6 mg/ml),
and 0.1 M Tris-HCl, pH 8.5. The stained cells were observed by phase-contrast
microscopy.
Immunoblot Analysis
C2C12 cells were washed twice with phosphate-buffered saline and then
lysed in a solution containing 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 20 mM
Na3VO4, 20 mM NaF, 5 mM EDTA, 0.3% Triton X-100, phosphatase inhibitor
cocktail, and protease inhibitor cocktail. The lysates were analyzed for protein
content with the use of a DC Protein Assay Kit (Bio-Rad, Hercules, CA), and
equal amounts of total lysate protein were subjected to SDS-PAGE. The
separated proteins were transferred to a polyvinylidene diﬂuoride membrane
(Bio-Rad), nonspeciﬁc sites of which were blocked before its consecutive
exposure to primary antibodies and horseradish peroxidase–conjugated sec-
ondary antibodies (Promega, Madison, WI). Immune complexes were de-
tected with the use of a Chemi-Lumi One detection kit (Nacalai Tesque,
Kyoto, Japan) and Amersham Hyperﬁlm ECL (GE Healthcare/Amersham
Figure 1. Expression of PDZRN3 and Runx2 during BMP-2–induced
differentiation of C2C12 cells into osteoblasts. (A) C2C12 cells were
cultured in low-serum medium with or without BMP-2 (100 ng/ml).
After 3 d, the cells were stained for ALP and observed by phase-
contrast microscopy (top panels); bar, 50 m. Cell lysates prepared at
the indicated times were assayed for ALP activity with pNPP as sub-
strate (bottom panel). Data are expressed as a percentage of the value
for cells exposed to BMP-2 for 4 d and are means  SEM from ﬁve
independent experiments. *p  0.05, ***p  0.001 versus the corre-
sponding value for cells cultured in the absence of BMP-2. (B) Total
RNA prepared from cells cultured as in A was subjected to RT-PCR
analysis of Runx2 and G3PDH (control) mRNAs. (C) Lysates of cells
cultured as in A were subjected to immunoblot analysis with antibod-
ies to PDZRN3 (top panel). The intensity of the PDZRN3 band was
measured by image analysis and expressed as a percentage of the value
at time 0 (bottom panel); data are means  SEM from six independent
experiments. *p 0.05, ***p 0.001 versus the corresponding value for
cells cultured in the absence of BMP-2. (D) Total RNA prepared from
cells cultured as in A was subjected to RT-PCR analysis of PDZRN3
and G3PDH mRNAs.
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with an ATTO Lane & Spot Analyzer (ATTO, Tokyo, Japan).
RT-PCR Analysis
Total RNA was prepared from C2C12 cells with the use of an SV total RNA
isolation system (Promega). Reverse transcription (RT) and PCR analysis was
performed with 100 ng of total RNA and with the use of a Superscript One-Step
RT-PCR system (Invitrogen) under conditions that maintain ampliﬁcation in the
exponential phase. The sequences of the PCR primers (sense and antisense,
respectively) were 5-CTGACTCTTGTCCTGCATCGGGACTC-3 and 5-
ATGGGCTCCTTGGCTGTCTTGAAAGC-3 for PDZRN3, 5-CAGGAAGACT-
GCAAGAAGGCTCTGG-3 and 5-ACACGGTGTCACTGCGCTGAAGA-3
for Runx2, 5-GACCAGTACAAGCCACTGGA-3 and 5-ATCTGTGGTTGTT-
GAGTAGG-3 for Smad6, 5-CAGATTCCCAACTTCTTCTG-3 and 5-
GTTGAAGATGACCTCCAGCC-3 for Smad7, 5-TCCTGCAGCATGTAATC-
GAC-3 and 5-GAGAGGGTGAGGCTCTGTTG-3 for Id1, 5-
ACCTCAATGCGATTTGTTCC-3 and 5-GGTGTCAAAGAAGCCTCTGC-3
for LRP6, and 5-ACCACAGTCCATGCCATCAC-3 and 5-TCCACCACCCT-
GTTGCTGTA-3 for glyceraldehyde-3-phosphate dehydrogenase (G3PDH).
Analysis of Cytosolic -Catenin Level
C2C12 cells were washed twice with a solution containing 150 mM NaCl, 2 mM
CaCl2, and 20 mM Tris-HCl, pH 7.5, and were then scraped into a solution
containing 150 mM NaCl, 2 mM dithiothreitol, 20 mM Tris-HCl, pH 7.5, and
protease inhibitor cocktail. The cells were homogenized with the use of a Poly-
tron disrupter, and the homogenate was centrifuged at 500  g for 10 min at 4°C.
The resulting supernatant was centrifuged at 100,000  g for 30 min at 4°C to
yield a cytosolic fraction (supernatant). The fraction was assayed for protein
content, and equal amounts of protein were subjected to immunoblot analysis
with antibodies to -catenin as described above.
Luciferase Reporter Assay
C2C12 cells in a 24-well plate were transfected for 16 h with 0.1 go ft h e
TCF/LEF reporter plasmid TOPﬂash or FOPﬂash as a negative control (Upstate
Biotechnology, Lake Placid, NY) and with 0.1 go fa-galactosidase expression
plasmid with the use of the Lipofectamine 2000 reagent (Invitrogen). The cells
were then exposed to Wnt3a (200 ng/ml) for 24 h, harvested, lysed, and assayed
for luciferase activity with the use of a Luciferase Assay System (Promega) and
a Perkin Elmer-Cetus 2030 Multilabel Reader ARVO X4 (Waltham, MA). For each
cell lysate, -galactosidase activity was also measured with o-nitrophenyl--d-
galactoside (Wako, Osaka, Japan) as a substrate to account for differences in
transfection efﬁciency. The relative luciferase activity (TOPﬂash/FOPﬂash) was
normalized by -galactosidase activity.
Statistical Analysis
Data are presented as means  SEM and were analyzed by Student’s t test.
p  0.05 was considered statistically signiﬁcant.
RESULTS
Expression of PDZRN3 during Osteoblast Differentiation
Whereas culture of C2C12 cells in low-serum medium con-
taining 2% horse serum induces their differentiation into
myotubes (Blau et al., 1985), culture in the additional pres-
ence of BMP-2 results in their differentiation into osteoblasts
(Katagiri et al., 1994), which is accompanied by increases in
both ALP activity (Figure 1A) and the abundance of Runx2
mRNA (Figure 1B). BMP-2 also markedly and rapidly in-
creased the expression of PDZRN3 at both the protein (Fig-
ure 1C) and mRNA (Figure 1D) levels. Although a small
increase in the abundance of PDZRN3 was apparent at 3 d
after the induction of myotube differentiation, a much larger
increase was apparent as early as 12 h after the induction of
osteoblast differentiation (Figure 1C). These results thus sug-
gested that PDZRN3 might play a role in the early phase of
C2C12 cell differentiation into osteoblasts.
Up-Regulation of ALP and Runx2 by RNA
Interference–mediated Depletion of PDZRN3
To clarify the potential role of PDZRN3 in osteoblast differ-
entiation of C2C12 cells, we examined the effect of PDZRN3
depletion by adenovirus-mediated expression of a shRNA
speciﬁc for PDZRN3 mRNA on ALP activity. Expression of
two different such shRNAs (KD-1 or -2) but not that of a
scrambled version of KD-1 (Scramb) resulted in a marked
Figure 2. Effect of RNA interference–mediated PDZRN3
depletion on the BMP-2–induced up-regulation of ALP
activity and Runx2 expression in C2C12 cells. (A) C2C12
cells were infected with adenoviral vectors encoding ei-
ther a shRNA speciﬁc for PDZRN3 mRNA (KD-1 or -2), a
scrambled version of KD-1 (Scramb), or PDZRN3 (OE) for
2 d in growth medium. Cell lysates were then prepared
and subjected to immunoblot analysis with antibodies to
PDZRN3 or to -tubulin (control). (B) C2C12 cells were
infected with adenoviral vectors for the PDZRN3 KD-1 or
Scramb shRNAs for2di ngrowth medium, after which
osteoblast differentiation was induced by replacement of
the medium with low-serum medium containing BMP-2
(100 ng/ml). Cell lysates prepared at the indicated times
thereafter were assayed for ALP activity. Data are ex-
pressed as nanomoles of pNPP hydrolyzed per milligram
of protein per minute and are from a representative ex-
periment. (C) Cells infected with adenoviral vectors as in
A were stained for ALP (top panels; bar, 50 m) and
assayed for ALP activity (bottom panel) 3 d after the
switch from growth medium to low-serum medium con-
taining BMP-2 (100 ng/ml). Quantitative data are
means SEM from four independent experiments. ***p 
0.001. (D) Cells infected with adenoviral vectors for
PDZRN3 KD-1 or Scramb shRNAs, or for PDZRN3 KD-1
shRNA plus a form of PDZRN3 mRNA resistant to KD-1
were induced to differentiate into osteoblasts by culture
f o r3di nlow-serum medium containing BMP-2 (100
ng/ml). Lysates of the cells were then subjected to immu-
noblot analysis with antibodies to PDZRN3 (top panel)
and assayed for ALP activity (bottom panel). Quantitative data are means  SEM from ﬁve independent experiments. ***p  0.001. (E) Cells were
infected with adenoviral vectors and induced to differentiate into osteoblasts as in B. Total RNA prepared from the cells at 6 h after the induction
of differentiation was subjected to RT-PCR analysis of Runx2 and G3PDH mRNAs. The amount of Runx2 mRNA was normalized by that of
G3PDH mRNA. Data are means  SEM from ﬁve independent experiments. **p  0.01.
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(Figure 2A). Depletion of PDZRN3 was associated with a
marked enhancement of the BMP-2–induced increase in
ALP activity compared with that apparent in cells express-
ing the scrambled shRNA (Figure 2, B and C). This effect of
PDZRN3 depletion by the KD-1 shRNA was eliminated
by adenovirus-mediated expression of PDZRN3 from an
mRNA that is resistant to KD-1 (Figure 2D). Depletion of
PDZRN3 also enhanced the BMP-2–induced increase in
Runx2 gene expression (Figure 2E). Under our experimental
conditions, the differentiation of C2C12 cells into chondro-
cytes and adipocytes was negligible and was not enhanced
by depletion of PDZRN3 (data not shown). These results
thus suggested that PDZRN3 might function as a negative
regulator in osteoblast differentiation. The BMP-2–induced
increase in ALP activity in PDZRN3-depleted C2C12 cells
was apparent not only in low-serum medium but also in
growth medium containing 10% fetal bovine serum (Figure
3). BMP-2 had little effect on ALP activity in C2C12 cells
expressing the scrambled shRNA and maintained in growth
medium. Adenovirus-mediated overexpression of PDZRN3
(Figure 2A) had no substantial effect on the BMP-2–induced
increase in ALP activity in cells cultured in low-serum me-
dium (Figure 2C).
Effects of PDZRN3 Depletion on BMP Signaling
We next examined the effects of PDZRN3 depletion on BMP
signaling in C2C12 cells. With regard to the Smad pathway,
the BMP-2 induced increases in the amounts of phosphory-
lated Smads 1 or 5 (Smad1/5) or of the mRNAs for the
inhibitory Smads (Smad6 and Smad7) were not affected
by depletion of PDZRN3 (Figure 4, A–C). Depletion of
PDZRN3 also had no substantial effect on the expression of
a representative BMP-responsive gene, that for Id1 (Figure
4D). With regard to the non-Smad pathways, the BMP-2–
induced increase in the amount of phosphorylated ERK1/2
was inhibited by depletion of PDZRN3 (Figure 4E), whereas
the increases in the amounts of phosphorylated forms of
JNK or p38 MAPK were not affected by PDZRN3 depletion
(Figure 4, G and H). The BMP-2–induced phosphorylation of
the linker region of Smad1, which is catalyzed by ERK, was
also inhibited by depletion of PDZRN3 (Figure 4F).
Effects of PDZRN3 Depletion on Wnt Signaling
Various studies have indicated the existence of cross talk
between BMP and Wnt signaling pathways (Rawadi et al.,
2003; Nakashima et al., 2005; Vaes et al., 2005; Chen et al.,
2007; Fuentealba et al., 2007; de Jesus Perez et al., 2009; Sato
et al., 2009). We therefore examined whether Wnt signaling
might contribute to the observed potentiation of the BMP-
2–induced increase in ALP activity by PDZRN3 depletion.
We found that Dkk1, an inhibitor of Wnt signaling, reduced
ALP activity by 70% in BMP-2–treated cells expressing
PDZRN3 shRNA but by only 20% in those expressing the
scrambled shRNA (Figure 5). These results thus suggested
that Wnt signaling was enhanced in the PDZRN3-depleted
cells. This enhancement was likely not attributable to poten-
tiation of BMP-2–induced secretion of Wnt from the cells,
given that the abundance of mRNAs for Wnts (Wnt1, Wnt2,
and Wnt3a) that induce the expression of ALP (Milat and
Ng, 2009) was not increased by PDZRN3 depletion. The
amount of Wnt1 mRNA was actually lower in PDZRN3-
depleted cells, whereas that of Wnt2b mRNA did not differ
between the cells expressing PDZRN3 shRNA and those
expressing the scrambled shRNA and that of Wnt3a mRNA
was too low to detect (data not shown).
Wnt signaling plays an important role in osteoblast devel-
opment (Baron and Rawadi, 2007), and overexpression of
Wnt3a was previously shown to increase ALP activity in
C2C12 cells through canonical Wnt–-catenin signaling not
only in low-serum medium (Rawadi et al., 2003) but also in
growth medium (Nakashima et al., 2005). We therefore ex-
amined whether the Wnt3a-induced increase in ALP activity
is potentiated by PDZRN3 depletion. The Wnt3a-induced
increase in ALP activity was indeed markedly greater in
cells expressing PDZRN3 shRNA than in those expressing
the scrambled shRNA, regardless of whether the cells were
cultured in low-serum or growth medium (Figure 6). On the
other hand, overexpression of PDZRN3 had no substantial
effect on the Wnt3a-induced increase in ALP activity (data
not shown), because it failed to affect BMP-2–induced ALP
activity (Figure 2C). For cells cultured in growth medium,
the Wnt3a-induced increase in the cytosolic abundance of
-catenin, which results in an increase in the amount of
-catenin in the nucleus, was signiﬁcantly greater in cells
depleted of PDZRN3 than in those expressing the scrambled
shRNA (Figure 7A), indicating that canonical Wnt–-catenin
signaling was enhanced by PDZRN3 depletion. To conﬁrm
the participation of the canonical Wnt–-catenin pathway in
the enhancement of BMP-2–induced ALP activity apparent
in PDZRN3-depleted cells, we determined the amounts of
cytosolic -catenin after induction of osteoblast differentia-
tion by BMP-2. The BMP-2–induced increase in the abun-
dance of -catenin in the cytosol was indeed more pro-
nounced in cells expressing PDZRN3 shRNA than in those
expressing the scrambled shRNA, and this difference was
apparent in both low-serum and growth media (Figure 7, B
and C).
Figure 3. BMP-2–induced osteoblast differentiation of PDZRN3-de-
pleted cells in low-serum or growth medium. C2C12 cells infected with
adenoviral vectors encoding PDZRN3 KD-1 or Scramb shRNAs were
exposed to BMP-2 at the indicated concentrations in either low-serum
(A) or growth (B) medium for 3 d, after which the cells were stained for
ALP (top panels; bar, 50 m) and assayed for ALP activity (bottom
panels). Quantitative data are means  SEM from three independent
experiments. *p  0.05, **p  0.01, ***p  0.001.
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PDZRN3 was also conﬁrmed with a luciferase reporter assay
in C2C12 cells transfected with the plasmid TOPﬂash, whose
expression reﬂects that of Wnt–-catenin target genes. De-
pletion of PDZRN3 resulted in signiﬁcant enhancement of
the Wnt3a-induced increase in luciferase activity (Figure
8A). Consistent with the increased abundance of -catenin
in the cytosol (Figure 7A), the extent of phosphorylation of
-catenin by GSK3 was decreased in Wnt3a-stimulated
C2C12 cells that had been depleted of PDZRN3 (Figure 8B).
We then examined the expression of proteins that partici-
pate in Wnt–-catenin signaling, including that of APC,
Axin1, dishevelled2, frizzled1, frizzled4, frizzled6, GSK3,
LRP5, and LRP6. The abundance of LRP6 was increased,
whereas that of the other proteins was unaffected, in
PDZRN3-depleted cells (Figure 8, C and D). In contrast, the
amount of LRP6 mRNA did not differ between cells express-
ing PZDRN3 shRNA or the scrambled shRNA (Figure 8E).
Finally, the Wnt3a-induced phosphorylation of LRP6 was
also enhanced in PDZRN3-depleted cells (Figure 8F), sug-
gesting that PDZRN3 negatively regulates Wnt–-catenin
signaling by reducing both the expression and Wnt3a-in-
duced phosphorylation of LRP6.
DISCUSSION
The differentiation of C2C12 cells into osteoblasts induced
by BMP-2 was found to be accompanied by early up-regu-
Figure 4. Effects of PDZRN3 depletion on BMP-2 signaling in C2C12 cells. C2C12 cells infected with adenoviral vectors for PDZRN3 KD-1
or Scramb shRNAs were induced to differentiate into osteoblasts by culture in low-serum medium containing BMP-2 (100 ng/ml). Cell lysates
prepared at the indicated times thereafter were subjected to immunoblot analysis with antibodies to Smad1/5/8 or to phosphorylated (p-)
Smad1/5 (A), to ERK1/2 or to phosphorylated ERK1/2 (E), to Smad1/5/8 or to phosphorylated Smad1 linker (Ser206) (F), to p38 MAPK or
to phosphorylated p38 (G), or to JNK or to phosphorylated JNK (H). Total RNA also prepared from the cells at the indicated times was
subjected to RT-PCR analysis of Smad6 (B), Smad7 (C), or Id1 (D) mRNAs. The amounts of phosphorylated Smad1/5 at 30 min (A), Smad6
mRNA at 24 h (B), Smad7 mRNA at 24 h (C), Id1 mRNA at 24 h (D), phosphorylated ERK1/2 at 2 h (E), phosphorylated Smad1 linker at 2 h
(F), phosphorylated p38 at 60 min (G), and phosphorylated JNK at 1 h (H) were normalized by the abundance of the corresponding control
protein or mRNA and are presented as means  SEM from six to 10 independent experiments. **p  0.01, ***p  0.001.
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ence revealed that PDZRN3 inhibits the up-regulation of
ALP activity, a marker of osteoblast differentiation, as well
as that of the mRNA for Runx2, a key regulator of osteoblast
differentiation (Komori et al., 1997). PDZRN3 was also
shown to inﬂuence Wnt–-catenin signaling but not to affect
Smad or non-Smad pathways of BMP signaling with the
exception of that mediated by ERK1/2 (see below). Our
results thus suggest that the up-regulation of PDZRN3 dur-
ing BMP-2–induced differentiation of C2C12 cells into osteo-
blasts results in inhibition of Wnt–-catenin signaling and
therefore contributes to negative feedback control of the
differentiation process.
Wnt and BMP act synergistically to promote osteoblast
differentiation and the formation of new bone (Mbalaviele et
al., 2005; Chen et al., 2007). Both BMP-2 and Wnt3a induce
the expression of ALP in and extracellular matrix mineral-
ization by mesenchymal cells (Rawadi et al., 2003). Whereas
the induction of ALP by Wnt3a is independent of BMP
signaling, that by BMP-2 relies at least in part on Wnt–-
catenin signaling and is associated with increased Wnt ex-
pression (Rawadi et al., 2003). Several observations in the
present study now suggest that PDZRN3 regulates Wnt–-
catenin signaling during BMP-2–induced differentiation of
C2C12 cells into osteoblasts: 1) Depletion of PDZRN3 in
C2C12 cells by RNA interference did not affect the activation
of Smad1/5 or the expression of Smad6 or Smad7 genes. 2)
Dkk1, an inhibitor of Wnt signaling, attenuated the enhance-
ment of the BMP-2–induced increase in ALP activity appar-
ent in PDZRN3-depleted cells. 3) Depletion of PDZRN3
enhanced not only the increase in ALP activity induced by
BMP-2 but also that induced by Wnt3a. 4) Depletion of
PDZRN3 conferred on BMP-2 the ability to increase ALP
activity in cells maintained in growth medium as well as in
those cultured in low-serum medium. The induction of ALP
in C2C12 cells by Wnt3a was previously observed not only
in low-serum medium (Rawadi et al., 2003; Nakashima et al.,
2005) but also in growth medium (Lu et al., 2008), whereas
that by BMP-2 is evident only in low-serum medium. 5) The
BMP-2–induced increase in the cytosolic abundance of
-catenin was enhanced in cells depleted of PDZRN3.
We have shown that PDZRN3 is up-regulated by BMP-2
and that it plays an important role in negative feedback
control of BMP-2–induced osteoblast differentiation in mes-
enchymal cells through inhibition of Wnt–-catenin signal-
ing. Sclerostin, a secreted cysteine-knot protein expressed
primarily in bone, seems to have a similar mode of action in
negative regulation of BMP-2–induced osteoblast differenti-
ation and bone formation. It is up-regulated by BMP (Ka-
miya et al., 2008) and inhibits Wnt–-catenin signaling but
not the Smad pathway of BMP signaling, with the inhibition
of Wnt–-catenin signaling being mediated by binding of
sclerostin to LRP5 or LRP6 (Li et al., 2005; Semenov et al.,
2005). However, it is not known whether sclerostin sup-
presses the expression of LRP6, an effect demonstrated for
PDZRN3 in the present study.
Figure 6. Effect of PDZRN3 depletion on the
Wnt3a-induced increase in ALP activity in
C2C12 cells. (A and B) C2C12 cells infected with
adenoviral vectors for PDZRN3 KD-1 or Scramb
shRNAs were induced to differentiate into osteo-
blasts by exposure for3dt ovarious concentra-
tions of Wnt3a in low-serum (A) or growth (B)
medium. Cell lysates were then prepared and
assayed for ALP activity. Data are from a repre-
sentative experiment. (C) ALP activities of cells
treated as in A and B, and exposed to Wnt3a at
400 ng/ml. Data are expressed relative to the
corresponding value for cells expressing the
Scramb shRNA and are means  SEM from ﬁve
independent experiments. **p  0.01.
Figure 5. Effect of Dkk1 on the BMP-2–induced increase in ALP
activity in PDZRN3-depleted cells. (A) C2C12 cells infected with
adenoviral vectors for PDZRN3 KD-1 or Scramb shRNAs were
induced to differentiate into osteoblasts by culture for3di nlow-
serum medium containing BMP-2 (50 ng/ml) and the indicated
concentrations of Dkk1. Cell lysates were then prepared and as-
sayed for ALP activity. Data are from a representative experiment.
(B) ALP activities of cells treated as in A and exposed to Dkk1 at 200
ng/ml. Data are expressed relative to the corresponding value for
cells cultured in the absence of Dkk1 and are means  SEM from
nine independent experiments. ***p  0.001.
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was attenuated in PDZRN3-depleted cells. ERK1/2 phosphor-
ylates Smad1 in its linker region and thereby inhibits the
nuclear accumulation of Smad1 (Kretzschmar et al., 1997).
Figure 7. Effects of PDZRN3 depletion on the cytosolic
abundance of -catenin during BMP-2– or Wnt3a-in-
duced osteoblast differentiation. C2C12 cells infected
with adenoviral vectors for PDZRN3 KD-1 or Scramb
shRNAs were induced to differentiate into osteoblasts
by culture for the indicated times in growth medium
supplemented with either murine Wnt3a–containing
conditioned medium (A) or BMP-2 (100 ng/ml; B) or in
low-serum medium containing BMP-2 (100 ng/ml; C).
A cytosolic fraction was then prepared from the cells
and subjected to immunoblot analysis with antibodies
to -catenin (top panels). The levels of cytosolic -cate-
nin at 12 h (A), 24 h (B), or 48 h (C) were determined by
densitometry; data are expressed relative to the corre-
sponding value for cells expressing the Scramb shRNA
and are means  SEM from six or seven independent
experiments (bottom panels). **p  0.01, ***p  0.001
versus the corresponding value for cells expressing the
Scramb shRNA.
Figure 8. Enhancement of Wnt–-catenin sig-
naling by PDZRN3 depletion. (A) C2C12 cells
infected with adenoviral vectors for PDZRN3
KD-1 or Scramb shRNAs were transfected with
TOPﬂash or FOPﬂash luciferase plasmids and a
-galactosidase expression plasmid, cultured for
24 h in growth medium with or without Wnt3a
(200 ng/ml), and then harvested for determina-
tion of luciferase activity. The relative luciferase
activity (TOPﬂash/FOPﬂash) was normalized
by -galactosidase activity. Data are means 
SEM from six independent experiments. ***p 
0.001. (B and F) C2C12 cells infected with adeno-
viral vectors for PDZRN3 KD-1 or Scramb
shRNAs were induced to differentiate into os-
teoblasts by culture for 6 h (B) or the indicated
times (F) in growth medium supplemented with
murine Wnt3a–containing conditioned me-
dium. Cell lysates were then prepared and sub-
jected to immunoblot analysis (top panels) with
antibodies to phosphorylated (p-) -catenin or to
-catenin (B) or with those to phosphorylated
LRP6 or to LRP6 (F). The levels of phosphory-
lated -catenin (B) and phosphorylated LRP6 (F)
at 6 h were determined by densitometry and
normalized by the corresponding amounts of
-catenin and -tubulin, respectively; data are
expressed relative to the corresponding value
for cells expressing the Scramb shRNA and are
means  SEM from six to nine independent
experiments (bottom panels). ***p  0.001 ver-
sus the corresponding value for cells expressing
the Scramb shRNA. (C–E) Cell lysates prepared
from C2C12 cells infected with adenoviral vec-
tors for PDZRN3 KD-1 or Scramb shRNAs were
subjected to immunoblot analysis with antibod-
ies to LRP6, LRP5, GSK3, frizzled1, frizzled4,
frizzled6, dishevelled2, Axin1, APC, and -tu-
bulin (C). The abundance of LRP6 was determined by densitometry and normalized by that of -tubulin (D); data are expressed relative to the value
for cells expressing the Scramb shRNA and are means  SEM from 17 independent experiments. ***p  0.001 versus the value for cells expressing
the Scramb shRNA. Total RNA also prepared from the cells was subjected to RT-PCR analysis of LRP6 and G3PDH mRNAs (top panel in E). The
levels of LRP6 mRNA were determined by densitometry and normalized by the amount of G3PDH mRNA (bottom panel in E); data are expressed
relative to the value for cells expressing the Scramb shRNA and are means  SEM from ﬁve independent experiments.
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the linker region was also inhibited in cells depleted of
PDZRN3. The enhancement of BMP-2–induced up-regulation
of ALP activity by PDZRN3 depletion might thus result in part
from enhancement of BMP signaling. The observed effect of
Dkk1 (Figure 5A), however, indicated that 90% of the en-
hancement of the BMP-2–induced increase in ALP activity by
depletion of PDZRN3 was due to activation of Wnt signaling.
ERK might therefore not play a critical role in inhibition of the
BMP-2–induced increase in ALP activity by PDZRN3.
We previously showed that PDZRN3 is required for myo-
genic differentiation of C2C12 cells (Ko et al., 2006). We have
now shown that expression of PDZRN3 increases earlier and
to a greater extent during the differentiation of C2C12 cells
into osteoblasts than it does during their differentiation into
myotubes. Although up-regulation of PDZRN3 was appar-
ent at 12 h during osteoblast differentiation, it was not
observed until 3 d into myotube differentiation, after that of
myogenin and before that of myosin heavy chain (Ko et al.,
2006). Although we found that PDZRN3 inhibits Wnt–-
catenin signaling during osteoblast differentiation, it might
not inhibit such signaling during myogenic differentiation,
given that our previous study showed that depletion of
PDZRN3 inhibited myogenic differentiation without affect-
ing the expression of myogenin (Ko et al., 2006). Wnt–-
catenin signaling is thought to promote the differentiation of
myoblasts into myotubes in part by increasing the expres-
sion of myogenin (Rochat et al., 2004; Descamps et al., 2008).
PDZRN3 might thus contribute to different signaling path-
ways during osteoblast and myogenic differentiation.
Overexpression of PDZRN3 in cultured myotubes was
previously shown to attenuate agrin-induced clustering of
acetylcholine receptors, whereas depletion of endogenous
PDZRN3 by RNA interference enhanced such agrin-induced
receptor clustering (Lu et al., 2007). The interaction of mus-
cle-speciﬁc receptor tyrosine kinase and PDZRN3 was sug-
gested to underlie these observations (Lu et al., 2007), al-
though this kinase does not possess a PDZ domain or a
consensus-binding motif for a PDZ domain in its COOH-
terminus. Wnt–-catenin signaling was found to promote
agrin-induced clustering of acetylcholine receptors in cul-
tured myotubes in one study (Henriquez et al., 2008),
whereas it inhibited this effect in another study (Wang et al.,
2008). It thus remains unclear whether negative regulation
of Wnt–-catenin signaling by PDZRN3 is responsible for
the effect of PDZRN3 on agrin-induced clustering of acetyl-
choline receptors in myotubes.
Although depletion of PDZRN3 enhanced the BMP-2–in-
duced increase in ALP activity, overexpression of PDZRN3
had no substantial effect on this up-regulation of ALP activity.
The reason for this apparent discrepancy is unknown. Over-
expression of PDZRN3 in C2C12 cells depleted of PDZRN3
abolished the effect of such depletion on ALP activity but did
not result in a further decrease in this activity. The amount of
endogenous PDZRN3 might thus not be limiting for inhibition
of the BMP-2–induced increase in ALP activity.
Our analysis of Wnt–-catenin signaling proteins revealed
that PDZRN3 suppressed both the expression and Wnt3a-
induced phosphorylation of LRP6 in C2C12 cells. The
Wnt3a-induced phosphorylation of LRP6 results in inhibi-
tion of -catenin phosphorylation and degradation and the
consequent activation of Wnt-responsive genes (Tamai et al.,
2004). LRP6 thus appears to be critical in the negative reg-
ulation of Wnt-induced osteoblastic differentiation by
PDZRN3. Although the mechanism by which LRP6 is reg-
ulated by PDZRN3 remains to be determined, our observa-
tion that the amount of LRP6 mRNA was not increased in
PDZRN3-depleted cells suggests that PDZRN3 might regu-
late the stability of LRP6.
We have shown that PDZRN3 negatively regulates BMP-
2–induced osteoblastic differentiation of mesenchymal cells
through inhibition of Wnt–-catenin signaling. PDZRN3
likely promotes mesenchymal cell differentiation into myo-
tubes by a distinct mechanism. Given that it is expressed in
a variety of tissues including heart, skeletal muscle, liver,
and brain (Ko et al., 2006) and that it possesses multiple sites
for interaction with other proteins, PDZRN3 might perform
different functions by interacting with different binding pro-
teins in different cell types or in response to different stimuli.
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